Odyssey Health (ODYY) Receivables (2016 - 2024)
Odyssey Health's quarterly Receivables came in at $45250.0 in Q3 2024, up 4201.33% quarter-over-quarter from $1052.0 in Q4 2017.
Odyssey Health has reported Receivables for 3 years, with the latest figure at $45250.0 in Q3 2024.
- For the quarter ending Q3 2024, Receivables changed N/A year-over-year to $45250.0; the trailing twelve-month figure through Jul 2024 stood at $45250.0 (changed N/A YoY), and the FY2024 full-year result was $45250.0, changed N/A from the prior year.
- Receivables for Q3 2024 stood at $45250.0, up from $1052.0 in the prior quarter.
- The five-year high for Receivables was $45250.0 in Q3 2024, with the low at $45250.0 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.21 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.57 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.36 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.15 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 973.00 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.82 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1.11 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 4.50 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 1.09 Bn |
| 10 | Odyssey Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2024 | 45,250.00 |
| Oct 31, 2017 | 1,052.00 |
| Jul 31, 2017 | 1,052.00 |
| Apr 30, 2017 | 1,052.00 |
| Jan 31, 2017 | 1,052.00 |
| Oct 31, 2016 | 11,052.00 |
| Jul 31, 2016 | 18,052.00 |
| Apr 30, 2016 | 22,500.00 |